BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32302384)

  • 1. Conditioned medium of the osteosarcoma cell line U2OS induces hBMSCs to exhibit characteristics of carcinoma-associated fibroblasts via activation of IL-6/STAT3 signalling.
    Lin L; Huang K; Guo W; Zhou C; Wang G; Zhao Q
    J Biochem; 2020 Sep; 168(3):265-271. PubMed ID: 32302384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
    Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
    Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
    Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
    Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-208a promotes osteosarcoma cell proliferation, migration, and invasion.
    Qin F; Tang H; Zhang Y; Zhang Z; Huang P; Zhu J
    J Cell Physiol; 2020 May; 235(5):4734-4745. PubMed ID: 31637737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
    Li P; Shi X; Xu Y; Zhong B; Lu Y; Sun Y
    Med Sci Monit; 2018 Nov; 24():7802-7808. PubMed ID: 30381753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
    Pelagalli A; Nardelli A; Fontanella R; Zannetti A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
    Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
    Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.
    Wang Y; Chu Y; Yue B; Ma X; Zhang G; Xiang H; Liu Y; Wang T; Wu X; Chen B
    Oncotarget; 2017 Apr; 8(14):23803-23816. PubMed ID: 28423603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
    BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
    IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion.
    Yu FX; Hu WJ; He B; Zheng YH; Zhang QY; Chen L
    World J Surg Oncol; 2015 Feb; 13():52. PubMed ID: 25890096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
    Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
    Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
    Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidural adipose tissue-derived mesenchymal stem cell activation induced by lung cancer cells promotes malignancy and EMT of lung cancer.
    Wang Y; Chu Y; Ren X; Xiang H; Xi Y; Ma X; Zhu K; Guo Z; Zhou C; Zhang G; Chen B
    Stem Cell Res Ther; 2019 Jun; 10(1):168. PubMed ID: 31196220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
    Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.